Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.33B | 5.34B | 4.81B | 4.57B | 4.38B | 3.08B | Gross Profit |
2.20B | 2.31B | 2.07B | 2.01B | 2.23B | 1.55B | EBIT |
313.78M | 351.87M | 399.54M | 343.25M | 777.55M | 517.68M | EBITDA |
413.35M | 381.94M | 492.07M | 254.95M | 804.53M | 521.75M | Net Income Common Stockholders |
61.36M | 67.48M | 244.52M | 62.79M | 448.08M | 293.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.18B | 3.74B | 3.45B | 2.37B | 2.18B | 2.00B | Total Assets |
4.29B | 8.32B | 4.68B | 3.80B | 3.77B | 3.14B | Total Debt |
224.00M | 2.60B | 300.00M | 0.00 | 0.00 | 0.00 | Net Debt |
-2.73B | -975.77M | -2.98B | -2.30B | -2.18B | -2.00B | Total Liabilities |
849.00M | 4.25B | 1.11B | 614.63M | 747.46M | 605.71M | Stockholders Equity |
3.39B | 3.39B | 3.53B | 3.16B | 2.98B | 2.51B |
Cash Flow | Free Cash Flow | ||||
0.00 | 102.65M | 275.36M | -758.00K | 337.81M | 353.62M | Operating Cash Flow |
0.00 | 132.98M | 345.30M | 113.19M | 466.46M | 422.79M | Investing Cash Flow |
0.00 | -1.68B | 236.38M | -191.93M | -283.61M | -349.17M | Financing Cash Flow |
0.00 | 1.91B | 403.47M | 131.49M | -17.00K | 1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥2.82B | 11.30 | 2.59% | 5.84% | 7.76% | ||
70 Outperform | ¥2.61B | 21.95 | 2.19% | 18.87% | ― | ||
69 Neutral | ¥3.12B | 9.96 | 2.72% | 11.74% | -9.04% | ||
62 Neutral | ¥2.76B | 40.60 | 3.89% | 11.03% | -73.41% | ||
62 Neutral | $11.80B | 10.08 | -7.46% | 2.99% | 7.37% | -8.21% | |
52 Neutral | ¥4.12B | ― | ― | 2.84% | 40.04% | ||
48 Neutral | ¥2.48B | ― | ― | -4.53% | -247.19% |